Mercator Medical S.A. (FRA:MM2)
Germany flag Germany · Delayed Price · Currency is EUR
8.99
-0.11 (-1.21%)
At close: Dec 5, 2025

Mercator Medical Statistics

Total Valuation

FRA:MM2 has a market cap or net worth of EUR 85.00 million. The enterprise value is 41.76 million.

Market Cap 85.00M
Enterprise Value 41.76M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date Nov 28, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 6.49M
Shares Outstanding n/a
Shares Change (YoY) -1.96%
Shares Change (QoQ) +12.69%
Owned by Insiders (%) n/a
Owned by Institutions (%) 1.71%
Float 3.79M

Valuation Ratios

The trailing PE ratio is 3.71.

PE Ratio 3.71
Forward PE n/a
PS Ratio 0.62
PB Ratio 0.41
P/TBV Ratio 0.42
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 33.34, with an EV/FCF ratio of -1.78.

EV / Earnings 1.82
EV / Sales 0.30
EV / EBITDA 33.34
EV / EBIT n/a
EV / FCF -1.78

Financial Position

The company has a current ratio of 6.95, with a Debt / Equity ratio of 0.03.

Current Ratio 6.95
Quick Ratio 3.73
Debt / Equity 0.03
Debt / EBITDA 4.43
Debt / FCF -0.24
Interest Coverage -38.74

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -1.86%
Revenue Per Employee 144,453
Profits Per Employee 24,115
Employee Count 950
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -5.15M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -18.31% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -18.31%
50-Day Moving Average 9.43
200-Day Moving Average 10.21
Relative Strength Index (RSI) 44.06
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:MM2 had revenue of EUR 137.23 million and earned 22.91 million in profits. Earnings per share was 2.47.

Revenue 137.23M
Gross Profit 37.88M
Operating Income -4.03M
Pretax Income 17.80M
Net Income 22.91M
EBITDA 1.25M
EBIT -4.03M
Earnings Per Share (EPS) 2.47
Full Income Statement

Balance Sheet

The company has 47.69 million in cash and 5.53 million in debt, giving a net cash position of 42.16 million.

Cash & Cash Equivalents 47.69M
Total Debt 5.53M
Net Cash 42.16M
Net Cash Per Share n/a
Equity (Book Value) 208.59M
Book Value Per Share 22.58
Working Capital 111.29M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.97 million and capital expenditures -9.44 million, giving a free cash flow of -23.41 million.

Operating Cash Flow -13.97M
Capital Expenditures -9.44M
Free Cash Flow -23.41M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 27.60%, with operating and profit margins of -2.94% and 16.69%.

Gross Margin 27.60%
Operating Margin -2.94%
Pretax Margin 12.97%
Profit Margin 16.69%
EBITDA Margin 0.91%
EBIT Margin -2.94%
FCF Margin n/a

Dividends & Yields

FRA:MM2 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 1.96%
Shareholder Yield 1.96%
Earnings Yield 26.95%
FCF Yield -27.55%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:MM2 has an Altman Z-Score of 4.82 and a Piotroski F-Score of 1.

Altman Z-Score 4.82
Piotroski F-Score 1